• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

Introduction to 3-(4-bromo-2,5-difluorophenoxy)propanenitrile (CAS No. 1379364-31-4)

3-(4-bromo-2,5-difluorophenoxy)propanenitrile, with the chemical formula C?H?BrF?NO, is a significant compound in the field of pharmaceutical and agrochemical research. This compound belongs to the class of halogenated aromatic ethers and has garnered considerable attention due to its unique structural properties and potential applications. The presence of both fluorine and bromo substituents in its aromatic ring makes it a versatile intermediate for synthesizing various biologically active molecules.

The compound's molecular structure features a propanenitrile side chain attached to a phenoxy group, which is further substituted with bromine and fluorine atoms at the 4th and 2,5th positions, respectively. This specific arrangement of functional groups enhances its reactivity and makes it a valuable building block in organic synthesis. The CAS no. 1379364-31-4 uniquely identifies this compound in scientific literature and databases, facilitating accurate referencing and research.

In recent years, the demand for halogenated aromatic compounds has surged due to their role in developing novel pharmaceuticals and agrochemicals. The introduction of fluorine and bromine atoms into aromatic rings often enhances the metabolic stability and binding affinity of drug candidates. This compound, in particular, has been explored in the synthesis of kinase inhibitors, which are crucial in treating various cancers and inflammatory diseases. The nitrile group in its structure also provides a site for further functionalization, allowing chemists to tailor its properties for specific applications.

One of the most compelling aspects of 3-(4-bromo-2,5-difluorophenoxy)propanenitrile is its utility as a precursor in the development of small-molecule drugs. Researchers have leveraged its reactive sites to create derivatives with enhanced pharmacological profiles. For instance, studies have shown that modifications at the nitrile or phenoxy positions can significantly alter the compound's bioactivity. This flexibility makes it an attractive candidate for high-throughput screening campaigns aimed at identifying new therapeutic agents.

The synthesis of 3-(4-bromo-2,5-difluorophenoxy)propanenitrile typically involves multi-step organic reactions, starting from commercially available aromatic precursors. The process often requires careful control of reaction conditions to ensure high yield and purity. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, have been employed to introduce the halogen atoms efficiently. These methods not only improve the synthetic route but also minimize unwanted byproducts, making the process more sustainable.

The pharmacological potential of this compound has been investigated in several preclinical studies. Its structural features suggest that it may interact with biological targets involved in disease pathways. For example, researchers have hypothesized that it could modulate the activity of enzymes such as tyrosine kinases, which are overactive in many cancers. Additionally, its ability to cross the blood-brain barrier makes it a candidate for treating neurological disorders.

In agrochemical applications, 3-(4-bromo-2,5-difluorophenoxy)propanenitrile has been explored as a component in pesticide formulations. Its chemical stability under environmental conditions ensures prolonged activity once applied to crops. Furthermore, its selective toxicity towards certain pests while being less harmful to beneficial insects makes it an environmentally friendly option. This dual functionality—pharmaceutical relevance and agrochemical utility—underscores its importance as a versatile chemical intermediate.

The regulatory landscape for halogenated compounds like 3-(4-bromo-2,5-difluorophenoxy)propanenitrile is stringent but well-established. Manufacturers must adhere to guidelines set by agencies such as the FDA and EMA to ensure safety and efficacy. These regulations cover aspects ranging from production methodologies to environmental impact assessments. Compliance with these standards is essential for commercializing products derived from this compound.

Future research directions for 3-(4-bromo-2,5-difluorophenoxy)propanenitrile include exploring novel synthetic pathways that enhance yield and reduce waste. Additionally, computational modeling techniques are being employed to predict how structural modifications will affect bioactivity. These advancements will accelerate the discovery of new derivatives with improved properties.

The role of this compound in drug discovery is expected to grow as pharmaceutical companies continue to seek innovative solutions for unmet medical needs. Its unique combination of structural features makes it a valuable asset in medicinal chemistry libraries. By leveraging its potential through continued research and development, scientists can unlock new therapeutic possibilities.

• 1881292-82-5(1-Bromo-2,5-difluoro-4-propoxybenzene)
• 137812-27-2
• 1379301-44-6(2-(4-Bromo-2,5-difluoro-phenoxy)acetonitrile)
• 1826110-08-0(1-Bromo-4-Ethoxy-2,5-Difluorobenzene)
• 2445646-81-9(Acetonitrile, 2-(4-bromo-2,3-difluorophenoxy)-)
• 887582-69-6(1-Bromo-2,3-difluoro-4-propoxybenzene)
• 1152534-11-6(4-(4-bromo-2-fluorophenoxy)butanenitrile)
• 247176-22-3(1-Bromo-4-butoxy-2,3-difluorobenzene)
• 2121514-69-8(5-Bromo-1,4-difluoro-2-isopropoxybenzene)
• 1235548-06-7(1-Bromo-4-butoxy-2,5-difluorobenzene)